Spire Healthcare Group (LON:SPI) Trading 13.8% Higher - Here's What Happened

Key Points

• Sspire Healthcare Group's shares rose by 13.8% to close at GBX 246.43 ($3.34) amid significantly increased trading volume of 42,338,680 shares.
• Analysts maintain a positive outlook, with a buy rating from Berenberg Bank and a revised price target between GBX 280 and GBX 303, reflecting confidence in the company's growth potential.
• The company reported an EPS of GBX 4.10 for the last quarter, with forecasts estimating a total of 15.66 EPS for the current year, indicating potential for earnings growth.

Spire Healthcare Group plc (LON:SPI - Get Free Report) shares were up 13.8% during mid-day trading on Friday . The company traded as high as GBX 256.50 ($3.47) and last traded at GBX 246.43 ($3.33). Approximately 42,338,680 shares traded hands during trading, an increase of 2,469% from the average daily volume of 1,648,148 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analysts Set New Price Targets

A number of analysts have recently issued reports on SPI shares. Berenberg Bank reiterated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. decreased their price objective on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Stock Down 4.7%

The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25. The stock has a 50 day simple moving average of GBX 218.99 and a 200 day simple moving average of GBX 203.96. The firm has a market capitalization of £947.58 million, a PE ratio of 5,119.57, a PEG ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. As a group, sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.